Results 221 to 230 of about 389,571 (303)

Eco‐anxiety in Tampa Bay: Prevalence, risk factors and recommendations for environmental practitioners

open access: yesPeople and Nature, EarlyView.
Abstract As the environmental crisis grows, concerns over its impact on mental health are rising. A growing body of research is investigating novel ecological emotions, with eco‐anxiety garnering significant attention. Yet much of the discourse has centred around clinical implications, leaving environmental practitioners feeling powerless to address ...
B. Alexander Simmons
wiley   +1 more source

Optical mapping reveals a higher level of large‐scale structural variants in a family with paternally transmitted myotonic dystrophy and independent Parkinson's disease

open access: yesThe Journal of Pathology, EarlyView.
Abstract Myotonic dystrophy type 1 (DM1) is a clinically challenging multisystem neuromuscular hereditary disorder, with generational increase in severity and earlier age at onset. It is caused by an unstable cytosine‐thymine‐guanine repeat expansion at the DMPK locus, accompanied by associated genetic and epigenetic modifications.
Md Mehedi Hasan   +9 more
wiley   +1 more source

Predicting brain age in children aged 2–6 years with autism spectrum disorders using routine T1‐ and T2‐weighted magnetic resonance imaging

open access: yesPediatric Investigation, EarlyView.
The routine magnetic resonance imaging‐based model accurately predicted brain age in children aged 2–6. Children with autism spectrum disorder (ASD) exhibited maturational delays at ages 3–5, shifting toward accelerated aging by age 5–6. This exploratory result highlights the dynamic, age‐related developmental heterogeneity in ASD.
Zunying Hu   +7 more
wiley   +1 more source

Safety of 12‐Months Administration of Ashwagandha (Withania somnifera) Standardized Root Extract in Healthy Adults: A Prospective, Observational Study

open access: yesPhytotherapy Research, EarlyView.
ABSTRACT Ashwagandha, an adaptogen, is an important herb of Ayurveda used as a Rasayana for its various health benefits. This prospective, multi‐center, observational clinical study evaluates the safety (clinical and laboratory) of a standardized Ashwagandha Root Extract (ARE) on long‐term administration over 12 months. Male and female adults (N = 191)
Jaising Salve   +6 more
wiley   +1 more source

A Schizophrenia‐Spectrum Presentation with Panda Sign: Huntington's Disease Confirmed, Wilson Disease Excluded

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Eva‐Maria Tsapakis   +5 more
wiley   +1 more source

Safety of 8‐Week Administration With Ashwagandha (Withania somnifera) Root Extract in Adults With Stress and Anxiety: Findings From a Prospective, Randomized, Multi‐Center, Double‐Blinded, Placebo‐Controlled Study

open access: yesPhytotherapy Research, EarlyView.
ABSTRACT Ashwagandha (Withania somnifera) has been recognized for enhancing physical strength, mental well‐being, and overall vitality. Despite its long‐standing use across generations, some clinical reports have noted occasional adverse events. This study compared the safety and tolerability of Ashwagandha Root Extract (ARE) in healthy adults.
Ketan Pakhale   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy